ArticleBMC clinical pathology2015

Comparison of targeted next-generation sequencing and Sanger sequencing for the detection of PIK3CA mutations in breast cancer.

Ruza Arsenic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.